Posted by Michael Wonder on 17 Oct 2019
Most state Medicaid programs continue to restrict access to hepatitis C medicines
16 October 2019 - Despite guidance from the federal government, most state Medicaid programs continue to deny hepatitis C treatments to beneficiaries, although more states are gradually easing restrictions, according to a new analysis.
Between November 2018 and July 2019, six states have either removed or eliminated restrictions based on a patient’s stage of liver disease, one state loosened rules that required patients to demonstrate they have not abused drugs or alcohol for a period of time before starting treatment, and six states scaled back prescribing restrictions for health care providers.
